Life Sciences Times

Ginkgo Bioworks Launches COVID-19 Pooled Classroom Testing Pilot for K-12 Schools

A2 Biotherapeutics Enters Into Collaboration Agreement With Merck To Develop Allogeneic Cell Therapy

WHO chief calls for more investments in public health

This condition makes it hard for people to draw a mental picture

European nations begin Covid-19 vaccinations

India’s first fully indigenous pneumococcal vaccine launched

COVAXX and Aurobindo Pharma Announce COVID-19 Vaccine Partnership

Franklin Street Properties Corp. Announces the Sale of 4820 Emperor Boulevard in Durham, North Carolina for $89.7 Million

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

Innovative drug, Carrimycin, Receives FDA Approval for International, Multi-country Phase III Clinical Trial for the treatment of severe COVID-19 in hospitalized patients